About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Alzheimer's Disease Clinical Trials in Chicago | 167 Studies

Clinical Trials Alzheimer's DiseaseChicago

Alzheimer's Disease Clinical Trials in Chicago

Find 167 clinical trials for alzheimer's disease near Chicago, Illinois. Connect with research centers in your area.

All Alzheimer's Disease trials nationwide All trials in Chicago

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 61-80 of 167 trials

CompletedRosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's DiseaseRosiglitazone (RSG) has been tested in clinical studies and is approved by the FDA as a treatment for type II diabetes mellitus, a disease that occurs when the body is unable to…NCT00348140·Sun City, Arizona and 193 others

Alzheimer's Disease Trials in Other Cities

New York Los Angeles Houston Phoenix Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedIntelliCare in College Students - Implementation (ICCS-I)This study is a hybrid effectiveness-implementation trial of the smartphone student stress-management app IntelliCare for college students.NCT04108429·Chicago, Illinois

Active not recruitingStudy to Evaluate the Efficacy, Safety, and Tolerability of an Anti-MTBR Tau Monoclonal Antibody (BMS-986446) in Participants With Early Alzheimer's DiseaseThe purpose of this study is to assess the effectiveness, safety, and tolerability of BMS-986446 an Anti-MTBR Tau Monoclonal Antibody in participants with Early Alzheimer's…NCT06268886·Chandler, Arizona and 175 others

CompletedU.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce RiskThe purpose of this research study is to see if lifestyle changes can protect memory and thinking (cognition) as we age.NCT03688126·Sacramento, California and 5 others

TerminatedPhase 3 IGIV, 10% in Alzheimer´s DiseaseThe purpose of this study is to provide evidence of efficacy and safety to support the development of IGIV, 10% as a treatment option for patients with mild to moderate…NCT01524887·Birmingham, Alabama and 68 others

CompletedEARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD)12-week, open-label study to evaluate the effectiveness and safety of donepezil hydrochloride in Hispanic patients with mild to moderate Alzheimer's Disease (AD) in the U.S.NCT00230568·Phoenix, Arizona and 34 others

CompletedCB3 Pilot (Communication Bridge: A Person-centered Internet-based Intervention for Individuals With Primary Progressive Aphasia)This study will evaluate evidence-based treatments for adults with mild Primary Progressive Aphasia (PPA).NCT05697380·Chicago, Illinois

CompletedLife Enhancing Activities for Family Caregivers (LEAF 2.0)The goal of the proposed intervention, called LEAF (Life Enhancing Activities for Family Caregivers) is to reduce burden and increase well-being in Alzheimer's Disease caregivers…NCT03610698·Chicago, Illinois

CompletedA Phase 3 Study Evaluating Safety and Effectiveness of Immune Globulin Intravenous (IGIV 10%) for the Treatment of Mild-to-Moderate Alzheimer´s DiseaseThe purpose of this study was to evaluate the efficacy and safety of 2 doses of Immune Globulin Intravenous (IGIV), 10% administered every 2 weeks as an intravenous (IV) infusion…NCT00818662·Birmingham, Alabama and 40 others

TerminatedStudy of the Safety and Effectiveness of Two Doses of Investigational Study Drug EVP-6124 in Subjects With Alzheimer's DiseaseThe purpose of this study is to evaluate the safety and efficacy of 2 fixed doses of EVP-6124 compared to placebo for 26 weeks in subjects with mild to moderate Alzheimer's…NCT01969123·Phoenix, Arizona and 81 others

CompletedTricaprilin in Mild to Moderate Alzheimer's DiseaseThe purpose of this study is to evaluate the safety, tolerability and effectiveness of tricaprilin administered once a day for ninety days in subjects with mild to moderate…NCT00142805·Phoenix, Arizona and 24 others

TerminatedA Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's DiseaseThe primary objective of this study is to verify the clinical benefit of monthly doses of aducanumab in slowing cognitive and functional impairment as measured by changes in the…NCT05310071·Gilbert, Arizona and 264 others

CompletedIntelliCare Study: Artificial Intelligence in a Mobile (AIM) Intervention for DepressionThis study will evaluate and compare a smartphone intervention for depression and anxiety that uses machine learning to tailor treatment for participants with the same…NCT02801877·Chicago, Illinois

CompletedLong-term Safety and Tolerability of Idalopirdine (Lu AE58054) as Adjunctive Treatment to Donepezil in Patients With Mild-moderate Alzheimer's DiseaseTo evaluate the long-term safety and tolerability of idalopirdine (Lu AE58054) as adjunctive therapy to donepezil in patients with mild-moderate Alzheimer's Disease (AD).NCT02079246·Birmingham, Alabama and 257 others

CompletedPreventing Medication Mismanagement in People Living With Dementia Through Automated Medication Dispensing With Facial Recognition and Video ObservationGlobally, \>47M individuals live with dementia, with new incidence of 7.7M annually.NCT06691256·Chicago, Illinois

Enrolling by invitationAlzheimer's Disease Neuroimaging Initiative 4The Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4) is a non-randomized, longitudinal, natural history study designed to validate biomarkers, improve clinical trial design…NCT05617014·Birmingham, Alabama and 64 others

UnknownVitamin E in Aging Persons With Down SyndromeThe goal of this study is to determine the safety and efficacy of the administration of vitamin E, which has been shown to delay the progression of Alzheimer's disease, in slowing…NCT00056329·Farmington, Connecticut and 21 others

CompletedIntelliCare in College StudentsThis study is an 8-week usability and feasibility trial of the smartphone student stress-management app IntelliCare for college students.NCT04035577·Chicago, Illinois

TerminatedGlobal Efficacy Study of MPC-7869 to Treat Patients With Alzheimer'sThis is a multinational, randomized, double blind, placebo controlled, parallel group study comparing the safety and efficacy of daily dosing of 800 mg twice daily MPC-7869 to…NCT00322036·Phoenix, Arizona and 91 others

CompletedSafety and Efficacy of Tafamidis in Patients With Transthyretin CardiomyopathyThis Phase 3 study will investigate the efficacy, safety and tolerability of an oral daily dose of 20 mg or 80 mg tafamidis meglumine capsules compared to placebo in subjects with…NCT01994889·Birmingham, Alabama and 79 others

PreviousPage 4 of 9Next

Other Conditions in Chicago

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia